These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 16708855)

  • 1. [New era for MS treatment. Severe setback when it comes to enthusiasm--highly effective agent caused serious adverse effects].
    Olsson T
    Lakartidningen; 2006 Apr 26-May 2; 103(17):1282-3. PubMed ID: 16708855
    [No Abstract]   [Full Text] [Related]  

  • 2. MS drug back on market under restricted program.
    FDA Consum; 2006; 40(4):7. PubMed ID: 17243280
    [No Abstract]   [Full Text] [Related]  

  • 3. Natalizumab: new drug. Multiple sclerosis: risky market approval.
    Prescrire Int; 2008 Feb; 17(93):7-10. PubMed ID: 18354844
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treating multiple sclerosis in the natalizumab era: risks, benefits, clinical decision making, and a comparison between North American and European Union practices.
    Giovannoni G; Kinkel P; Vartanian T
    Rev Neurol Dis; 2007; 4(4):184-93. PubMed ID: 18195670
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Natalizumab in multiple sclerosis: unclear patient benefits].
    Schipper JP
    Ned Tijdschr Geneeskd; 2007 Apr; 151(15):852-5. PubMed ID: 17472115
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A new approach for MS.
    Morrow T
    Manag Care; 2005 Jan; 14(1):85-7. PubMed ID: 15742758
    [No Abstract]   [Full Text] [Related]  

  • 7. New treatment for multiple sclerosis.
    FDA Consum; 2005; 39(1):6-7. PubMed ID: 15818796
    [No Abstract]   [Full Text] [Related]  

  • 8. Drug insight: using monoclonal antibodies to treat multiple sclerosis.
    Hohlfeld R; Wekerle H
    Nat Clin Pract Neurol; 2005 Nov; 1(1):34-44. PubMed ID: 16932490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fast track to MS drug.
    Sheridan C
    Nat Biotechnol; 2004 Aug; 22(8):939-41. PubMed ID: 15286635
    [No Abstract]   [Full Text] [Related]  

  • 10. Tysabri back on market.
    Sheridan C
    Nat Biotechnol; 2006 Aug; 24(8):874. PubMed ID: 16900111
    [No Abstract]   [Full Text] [Related]  

  • 11. MS drug withdrawn from market.
    FDA Consum; 2005; 39(3):3. PubMed ID: 16127808
    [No Abstract]   [Full Text] [Related]  

  • 12. New treatment, new hope for those with multiple sclerosis.
    Bren L
    FDA Consum; 2005; 39(2):10-7. PubMed ID: 16121419
    [No Abstract]   [Full Text] [Related]  

  • 13. Multiple sclerosis and Natalizumab.
    Fiore D
    Am J Ther; 2007; 14(6):555-60. PubMed ID: 18090880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rituximab as a highly effective treatment in a female adolescent with severe multiple sclerosis.
    Karenfort M; Kieseier BC; Tibussek D; Assmann B; Schaper J; Mayatepek E
    Dev Med Child Neurol; 2009 Feb; 51(2):159-61. PubMed ID: 19191848
    [No Abstract]   [Full Text] [Related]  

  • 15. Multiple sclerosis. Part 2: ophthalmic issues in MS therapy.
    Pula JH; Javed A
    Curr Opin Ophthalmol; 2009 Nov; 20(6):476-81. PubMed ID: 19816177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of multiple sclerosis with natalizumab (Tysabri) in a setting of melanoma].
    Schmutz JL; Barbaud A; Tréchot P
    Ann Dermatol Venereol; 2008 Oct; 135(10):725-6. PubMed ID: 18929933
    [No Abstract]   [Full Text] [Related]  

  • 17. Infliximab: new indication. Severe Crohn's disease in children: many unknowns.
    Prescrire Int; 2008 Aug; 17(96):145. PubMed ID: 19489184
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natalizumab: targeting alpha4-integrins in multiple sclerosis.
    Engelhardt B; Kappos L
    Neurodegener Dis; 2008; 5(1):16-22. PubMed ID: 18075270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Daclizumab treatment for multiple sclerosis.
    Kim SE
    Pharmacotherapy; 2009 Feb; 29(2):227-35. PubMed ID: 19170591
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Natalizumab (Tysabri)].
    Ravnborg M
    Ugeskr Laeger; 2007 Sep; 169(38):3184-7. PubMed ID: 17910826
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.